Most Part D Plans Cover at Least One Biologic DMARD
In most plans, patients required to pay coinsurance percentage, averaging 29.6 percent of drug costs
Women With HTN, Diabetes Less Likely to Use Alternative Rx
Lower odds for consulting complementary and alternative medicine practitioner, taking CAM
Review: Monitor Weight for Youth on Antipsychotics
SSRIs and SNRIs may improve weight status in short term, but not long term
Risk to Infant From SSRI Use in Late Pregnancy Deemed Small
Persistent pulmonary hypertension of newborn risk similar to women with untreated depression
ASCO: Elotuzumab Shows Benefit in Multiple Myeloma
Survival gains when elotuzumab was added to treatment
ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
ASCO: Lymph Node Sx Doesn’t Benefit All Melanoma Patients
Second study supports new immunotherapy for enhanced survival in advanced melanoma
Smoke Exposure May Create Need for More Anesthesia
Effect seems to extend to patients exposed to secondhand smoke, as well as smokers
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
ASCO: MMR Deficiency Predicts Pembrolizumab Response
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
